Ketamine’s promising potential to ease depression is one of the reasons why its use has recently skyrocketed in the US and ...

Studies show that antidepressants don’t always work. One psychologist explains how to take control of negative thoughts ...

The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

Patients who received the drug, called navacaprant, showed no more improvement in depressive symptoms than people who ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

Depression is a common mental health condition and mood disorder that causes a persistent feeling of sadness and loss of ...

Those on the extreme end of the depression spectrum face symptoms that impact their daily activities too and not just their ...

ADAM Collard has opened up about his secret battle with depression in 2024 – calling it “the hardest year of my life”. The ...

In zebrafish, ketamine causes changes a brain circuit involved in "giving up." That may help explain how the drug helps ...

Neumora Therapeutics, Inc. (NASDAQ:NMRA) stock traded lower after the company released data from the Phase 3 KOASTAL-1 Study ...

Jan 2 (Reuters) - Neumora Therapeutics' (NMRA.O), opens new tab shares tumbled more than 80% on Thursday after its experimental depression drug failed to reduce symptoms such as sadness and ...

Thomas Trutschel / Photothek via Getty Images Neumora Therapeutics reported its experimental depression drug didn't meet expectations, and shares plunged. The biopharmaceutical firm's navacaprant ...